Biometrics

• 

  Publication Venue For

  • Interim monitoring of sequential multiple assignment randomized trials using partial information. 2023
  • Group sequential testing for cluster randomized trials with time-to-event endpoint..  78:1353-1364. 2022
  • Estimating vaccine efficacy over time after a randomized study is unblinded..  78:825-838. 2022
  • Rejoinder: Estimating vaccine efficacy over time after a randomized study is unblinded..  78:848-851. 2022
  • A general framework for subgroup detection via one-step value difference estimation. 2022
  • Joint model for survival and multivariate sparse functional data with application to a study of Alzheimer's Disease..  78:435-447. 2022
  • Multisource single-cell data integration by MAW barycenter for Gaussian mixture models. 2022
  • Joint gene network construction by single-cell RNA sequencing data. 2022
  • Improving trial generalizability using observational studies. 2021
  • Estimation of the odds ratio in a proportional odds model with censored time-lagged outcome in a randomized clinical trial. 2021
  • Testing small study effects in multivariate meta-analysis..  76:1240-1250. 2020
  • Bayesian shrinkage estimation of high dimensional causal mediation effects in omics studies..  76:700-710. 2020
  • Semi-supervised validation of multiple surrogate outcomes with application to electronic medical records phenotyping..  75:78-89. 2019
  • Optimal two-stage dynamic treatment regimes from a classification perspective with censored survival data..  74:1180-1192. 2018
  • Sample size determination for GEE analyses of stepped wedge cluster randomized trials..  74:1450-1458. 2018
  • Modeling survival distribution as a function of time to treatment discontinuation: A dynamic treatment regime approach..  74:900-909. 2018
  • Report of the Editors-2017..  74:5-7. 2018
  • Biometrics, JABES and the International Biometric Society..  73:723-724. 2017
  • A semiparametric model for vQTL mapping..  73:571-581. 2017
  • Estimating optimal shared-parameter dynamic regimens with application to a multistage depression clinical trial..  72:865-876. 2016
  • PenPC: A two-step approach to estimate the skeletons of high-dimensional directed acyclic graphs..  72:146-155. 2016
  • Using decision lists to construct interpretable and parsimonious treatment regimes..  71:895-904. 2015
  • A penalized likelihood approach for investigating gene-drug interactions in pharmacogenetic studies..  71:529-537. 2015
  • Detecting clinically meaningful biomarkers with repeated measurements: An illustration with electronic health records..  71:478-486. 2015
  • Response to reader reaction..  71:267-273. 2015
  • Discussion of "Combining biomarkers to optimize patient treatment recommendation"..  70:707-710. 2014
  • Evaluating marker-guided treatment selection strategies..  70:489-499. 2014
  • Assessing the causal effect of organ transplantation on the distribution of residual lifetime..  69:820-829. 2013
  • Doubly-robust estimators of treatment-specific survival distributions in observational studies with stratified sampling..  69:830-839. 2013
  • A robust method for estimating optimal treatment regimes..  68:1010-1018. 2012
  • Biometrics. Report of the editors--2011..  68:vii-x. 2012
  • A moment-adjusted imputation method for measurement error models..  67:1461-1470. 2011
  • Insights on the robust variance estimator under recurrent-events model..  67:1564-1572. 2011
  • Improved doubly robust estimation when data are monotonely coarsened, with application to longitudinal studies with dropout..  67:536-545. 2011
  • A penalized likelihood approach for bivariate conditional normal models for dynamic co-expression analysis..  67:299-308. 2011
  • A generalized estimator of the attributable benefit of an optimal treatment regime..  66:512-522. 2010
  • Design and inference for cancer biomarker study with an outcome and auxiliary-dependent subsampling..  66:502-511. 2010
  • Regression on quantile residual life..  65:1203-1212. 2009
  • Shrinkage-based diagonal discriminant analysis and its applications in high-dimensional data..  65:1021-1029. 2009
  • Bayesian inference for smoking cessation with a latent cure state..  65:970-978. 2009
  • Gene-trait similarity regression for multimarker-based association analysis..  65:822-832. 2009
  • Latent-model robustness in joint models for a primary endpoint and a longitudinal process..  65:719-727. 2009
  • Weighted likelihood method for grouped survival data in case-cohort studies with application to HIV vaccine trials..  64:1247-1255. 2008
  • Improving efficiency of inferences in randomized clinical trials using auxiliary covariates..  64:707-715. 2008
  • "Smooth" semiparametric regression analysis for arbitrarily censored time-to-event data..  64:567-576. 2008